Clinical Trial Update: Sarizotan in the Treatment of Neuroleptic-induced Tardive Dyskinesia [NA]

View source ↗

Summary

This ClinicalTrials.gov update indicates that the sarizotan trial for neuroleptic-induced tardive dyskinesia has been terminated; no results are disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroleptic-induced Tardive Dyskinesia

Drugs mentioned

• Sarizotan (sarizotan)

Snippet

Sponsor: Centre for Addiction and Mental Health | Conditions: Neuroleptic-induced Tardive Dyskinesia | NA | Status: TERMINATED